Gould Capital’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4K | Hold |
400
| – | – | 0.02% | 101 |
|
|
2025
Q1 | $45.7K | Sell |
400
-200
| -33% | -$22.8K | 0.03% | 83 |
|
|
2024
Q4 | $30.2K | Hold |
600
| – | – | 0.02% | 100 |
|
|
2024
Q3 | $27.8K | Hold |
600
| – | – | 0.02% | 108 |
|
|
2024
Q2 | $19.5K | Hold |
600
| – | – | 0.01% | 125 |
|
|
2024
Q1 | $15.1K | Buy |
600
+100
| +20% | +$2.52K | 0.01% | 131 |
|
|
2023
Q4 | $16.2K | Hold |
500
| – | – | 0.01% | 140 |
|
|
2023
Q3 | $13.1K | Hold |
500
| – | – | 0.01% | 136 |
|
|
2023
Q2 | $11.1K | Hold |
500
| – | – | 0.01% | 140 |
|
|
2023
Q1 | $10.8K | Hold |
500
| – | – | 0.01% | 143 |
|
|
2022
Q4 | $10.2K | Hold |
500
| – | – | 0.01% | 146 |
|
|
2022
Q3 | $13K | Hold |
500
| – | – | 0.01% | 133 |
|
|
2022
Q2 | $12K | Hold |
500
| – | – | 0.01% | 135 |
|
|
2022
Q1 | $11K | Hold |
500
| – | – | 0.01% | 141 |
|
|
2021
Q4 | $10K | Buy |
+500
| New | +$10K | 0.01% | 158 |
|